238 related articles for article (PubMed ID: 25431942)
21. Implications of Enhancer Transcription and eRNAs in Cancer.
Adhikary S; Roy S; Chacon J; Gadad SS; Das C
Cancer Res; 2021 Aug; 81(16):4174-4182. PubMed ID: 34016622
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional enhancers: from properties to genome-wide predictions.
Shlyueva D; Stampfel G; Stark A
Nat Rev Genet; 2014 Apr; 15(4):272-86. PubMed ID: 24614317
[TBL] [Abstract][Full Text] [Related]
23. Enhancers: emerging roles in cell fate specification.
Ong CT; Corces VG
EMBO Rep; 2012 Apr; 13(5):423-30. PubMed ID: 22491032
[TBL] [Abstract][Full Text] [Related]
24. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer.
Heyn H; Vidal E; Ferreira HJ; Vizoso M; Sayols S; Gomez A; Moran S; Boque-Sastre R; Guil S; Martinez-Cardus A; Lin CY; Royo R; Sanchez-Mut JV; Martinez R; Gut M; Torrents D; Orozco M; Gut I; Young RA; Esteller M
Genome Biol; 2016 Jan; 17():11. PubMed ID: 26813288
[TBL] [Abstract][Full Text] [Related]
25. Sequence signatures extracted from proximal promoters can be used to predict distal enhancers.
Taher L; Smith RP; Kim MJ; Ahituv N; Ovcharenko I
Genome Biol; 2013; 14(10):R117. PubMed ID: 24156763
[TBL] [Abstract][Full Text] [Related]
26. Taking promoters out of enhancers in sequence based predictions of tissue-specific mammalian enhancers.
Herman-Izycka J; Wlasnowolski M; Wilczynski B
BMC Med Genomics; 2017 May; 10(Suppl 1):34. PubMed ID: 28589862
[TBL] [Abstract][Full Text] [Related]
27. Adult porcine genome-wide DNA methylation patterns support pigs as a biomedical model.
Schachtschneider KM; Madsen O; Park C; Rund LA; Groenen MA; Schook LB
BMC Genomics; 2015 Oct; 16():743. PubMed ID: 26438392
[TBL] [Abstract][Full Text] [Related]
28. EAGLE: An algorithm that utilizes a small number of genomic features to predict tissue/cell type-specific enhancer-gene interactions.
Gao T; Qian J
PLoS Comput Biol; 2019 Oct; 15(10):e1007436. PubMed ID: 31665135
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns.
Roh TY; Wei G; Farrell CM; Zhao K
Genome Res; 2007 Jan; 17(1):74-81. PubMed ID: 17135569
[TBL] [Abstract][Full Text] [Related]
30. Actors with Multiple Roles: Pleiotropic Enhancers and the Paradigm of Enhancer Modularity.
Sabarís G; Laiker I; Preger-Ben Noon E; Frankel N
Trends Genet; 2019 Jun; 35(6):423-433. PubMed ID: 31005339
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
32. TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity.
Sammons MA; Zhu J; Drake AM; Berger SL
Genome Res; 2015 Feb; 25(2):179-88. PubMed ID: 25391375
[TBL] [Abstract][Full Text] [Related]
33. Multifaceted regulation of enhancers in cancer.
Xiao Q; Xiao Y; Li LY; Chen MK; Wu M
Biochim Biophys Acta Gene Regul Mech; 2022 Aug; 1865(6):194839. PubMed ID: 35750313
[TBL] [Abstract][Full Text] [Related]
34. Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein beta binding sites.
Savic D; Roberts BS; Carleton JB; Partridge EC; White MA; Cohen BA; Cooper GM; Gertz J; Myers RM
Genome Res; 2015 Dec; 25(12):1791-800. PubMed ID: 26486725
[TBL] [Abstract][Full Text] [Related]
35. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.
Baubec T; Colombo DF; Wirbelauer C; Schmidt J; Burger L; Krebs AR; Akalin A; Schübeler D
Nature; 2015 Apr; 520(7546):243-7. PubMed ID: 25607372
[TBL] [Abstract][Full Text] [Related]
36. Beyond the ENCODE project: using genomics and epigenomics strategies to study enhancer evolution.
Sakabe NJ; Nobrega MA
Philos Trans R Soc Lond B Biol Sci; 2013 Dec; 368(1632):20130022. PubMed ID: 24218635
[TBL] [Abstract][Full Text] [Related]
37. Detection of epigenetic alterations using tiling arrays.
Cheung HH; Rennert OM; Lee TL
Methods Mol Biol; 2013; 1067():79-86. PubMed ID: 23975787
[TBL] [Abstract][Full Text] [Related]
38. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
39. Systematic identification and annotation of human methylation marks based on bisulfite sequencing methylomes reveals distinct roles of cell type-specific hypomethylation in the regulation of cell identity genes.
Liu H; Liu X; Zhang S; Lv J; Li S; Shang S; Jia S; Wei Y; Wang F; Su J; Wu Q; Zhang Y
Nucleic Acids Res; 2016 Jan; 44(1):75-94. PubMed ID: 26635396
[TBL] [Abstract][Full Text] [Related]
40. Immune disease-associated variants in gene enhancers point to BET epigenetic mechanisms for therapeutic intervention.
Tough DF; Prinjha RK
Epigenomics; 2017 Apr; 9(4):573-584. PubMed ID: 27925476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
